Drug intelligence / Profile preview

nicotinamide riboside

Development stage
Phase 4
Lead developer
Niagen Bioscience
Modality
Small Molecules
Administration
Oral
01

Overview

Nicotinamide riboside is a derivative of vitamin B3 (niacin) and serves as a precursor to nicotinamide adenine dinucleotide (NAD+), an essential coenzyme involved in cellular energy metabolism. Upon oral administration, it increases NAD+ levels in cells and tissues, which can activate sirtuin enzymes such as SIRT1 and SIRT3. These effects are associated with enhanced oxidative metabolism, improved mitochondrial function, neuroprotection in models of neurodegenerative disease (such as Alzheimer's disease), and potential benefits for metabolic health including protection against diet-induced metabolic abnormalities. Nicotinamide riboside is used primarily as a dietary supplement for its purported anti-aging properties and support of cellular energy production[1][2][4][6].

Brand names
Tru Niagen
Other names
烟酰胺核糖烟酰胺核苷Nicotinamide Riboside ChlorideNRCl
02

Targets

NMRK1 (Nicotinamide riboside kinase 1)

Beyond the preview

Go deeper on nicotinamide riboside.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nicotinamide riboside.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call